Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- 1st 3Qtrs Business Results
February 9, 2004
- Mochida's Reorganization Showing Steady Progress: Pres. Mochida
February 9, 2004
- MEDICAL DEVICE NEWS IN BRIEF
February 9, 2004
- Overview of US Drug Industry, Healthcare Presented: JPMA Seminar
February 9, 2004
- 1st 3Qtrs Business Results
February 9, 2004
- Antihistamic Drugs Marketing Stiffer Competition (2)
February 9, 2004
- Approval for Levitra, Sandostatin LAR Recommended
February 9, 2004
- BUSINESS NEWS IN BRIEF
February 9, 2004
- Website News
February 9, 2004
- Market-based Healthcare Reform Criticized: Seminar
February 2, 2004
- Korosho Proposes DPC Review Policy
February 2, 2004
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 2, 2004
- LTT Bio-Pharma Starts PI Trial on PC-SOD
February 2, 2004
- Iryo Proverbs Reveal Japanese Spirit (17)
February 2, 2004
- Korosho Policies to Support Pharmaceutical Research Explained: Symposium
February 2, 2004
- Taisho Toyama Making Radical Changes in Marketing Strategy
February 2, 2004
- Six-year Interim Report of Japan Diabetes Complications Study Published
February 2, 2004
- Semi-annual Business Results
February 2, 2004
- Korosho to Approve Drug Sales by TV Phone on April 1
February 2, 2004
- Kuraya Sanseido Integrating Systems, Marketing Strategies Newly Start on Oct. 1
February 2, 2004
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…